Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities

• Published in: Acta neuropathologica communications Vol. 5; no. 1; pp. 65 - 13
• Main Authors: Gauthier, Sébastien A., Pérez-González, Rocío, Sharma, Ajay, Huang, Fang-Ke, Alldred, Melissa J., Pawlik, Monika, Kaur, Gurjinder, Ginsberg, Stephen D., Neubert, Thomas A., Levy, Efrat
• Format: Journal Article
• Language: English
• Published: London BioMed Central 29.08.2017; BioMed Central Ltd; BMC
• Subjects: Adult; Aged; Alzheimer's disease; Analysis; Animals; Biomedical and Life Sciences; Biomedicine; Brain - pathology; Brain - secretion; CD63; Cells, Cultured; Disease Models, Animal; Down syndrome; Down Syndrome - metabolism; Down Syndrome - pathology; endosome; exosome; Exosomes - pathology; Exosomes - secretion; extracellular vesicle; Female; Fibroblasts - pathology; Fibroblasts - secretion; Hostages; Humans; Male; Mice, Transgenic; Middle Aged; Neurology; Neurons; Neuroprotection - physiology; Neurosciences; Pathology; rab GTP-Binding Proteins - metabolism; rab35; RNA, Messenger - metabolism; Tetraspanin 30 - metabolism; CD63; rab35; endosome; Down syndrome; extracellular vesicle; exosome
• ISSN: 2051-5960; 2051-5960
• DOI: 10.1186/s40478-017-0466-0

A dysfunctional endosomal pathway and abnormally enlarged early endosomes in neurons are an early characteristic of Down syndrome (DS) and Alzheimer’s disease (AD). We have hypothesized that endosomal material can be released by endosomal multivesicular bodies (MVBs) into the extracellular space via exosomes to relieve neurons of accumulated endosomal contents when endosomal pathway function is compromised. Supporting this, we found that exosome secretion is enhanced in the brains of DS patients and a mouse model of the disease, and by DS fibroblasts. Furthermore, increased levels of the tetraspanin CD63, a regulator of exosome biogenesis, were observed in DS brains. Importantly, CD63 knockdown diminished exosome release and worsened endosomal pathology in DS fibroblasts. Taken together, these data suggest that increased CD63 expression enhances exosome release as an endogenous mechanism mitigating endosomal abnormalities in DS. Thus, the upregulation of exosome release represents a potential therapeutic goal for neurodegenerative disorders with endosomal pathology.